FDA approves Octapharma’s latest therapy NUWIQ®, for people with hemophilia A. Clinical trial data showed good to excellent results overall.
↧
FDA approves Octapharma’s latest therapy NUWIQ®, for people with hemophilia A. Clinical trial data showed good to excellent results overall.